12021050 · Active · incorporated 7 years, 3 months ago · London
Biotech Biotech & Life Sciences Drug Discovery Healthcare Series A
Sentcell is a biotechnology company focused on developing treatments to target the pillars of ageing through selective rejuvenation of T cells.
Sentcell is a private limited company registered at Companies House under number 12021050, incorporated on 29 May 2019, with a registered office in London. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 41 filings for this company, including 2 funding rounds. Its most recent round closed in April 2021, raising £5.9m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 2 | Apr 2021 | £5.9m | £598.22 |
| Round 1 | Sep 2019 | £400k | £100.00 |
Showing the 10 most recent of 41 filings.
See the complete cap table with every shareholder, founder tags, dilution across 5 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.